Icon plc Stock
Price
Target price
€126.15
€126.15
-1.500%
-1.9
-1.500%
€263.97
13.06.25 / Tradegate
WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Icon plc Stock
A loss of -1.500% shows a downward development for Icon plc.
The stock is an absolute favorite of our community with 29 Buy predictions and no Sell predictions.
Based on the current price of 126.15 € the target price of 263 € shows a potential of 108.48% for Icon plc which would more than double the current price.
Pros and Cons of Icon plc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | -1.500% | 3.402% | -0.198% | -57.396% | -38.613% | -37.550% | - |
| Alkermes plc | -2.940% | -2.222% | -3.650% | 14.783% | -5.714% | 3.044% | 88.571% |
| Ironwood Pharmaceuticals | -10.320% | 14.837% | -7.377% | -89.820% | -86.548% | -94.909% | -93.025% |
| Arrowhead Pharmaceuticals Inc. | -2.640% | -7.564% | -0.220% | -44.793% | -26.331% | -49.853% | -53.146% |
Comments
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Mizuho from $200.00 to $173.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Mizuho from $238.00 to $200.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Citigroup Inc. from $290.00 to $215.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
News
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair
ICON releases its ICON Cares 2024 Report
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from